Patents by Inventor Charles G. Cochrane
Charles G. Cochrane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11413297Abstract: The invention provides compositions and methods for disrupting preformed bacterial biofilm or preventing formation of bacterial biofilm. Also provided in the invention are methods and compositions for treating and preventing chronic rhinosinusitis. Such compositions and methods utilize one or more antibiotic compounds in combination with at least one phospholipid compound described herein.Type: GrantFiled: September 21, 2018Date of Patent: August 16, 2022Assignees: AVANTI POLAR LIPIDS, LLC, THE SCRIPPS RESEARCH INSTITUTEInventors: Charles G. Cochrane, Ronald A. Simon, Stephen W. Burgess, Walter A. Shaw
-
Publication number: 20200306274Abstract: The invention provides compositions and methods for disrupting preformed bacterial biofilm or preventing formation of bacterial biofilm. Also provided in the invention are methods and compositions for treating and preventing chronic rhinosinusitis. Such compositions and methods utilize one or more antibiotic compounds in combination with at least one phospholipid compound described herein.Type: ApplicationFiled: September 21, 2018Publication date: October 1, 2020Inventors: Charles G. COCHRANE, Ronald A. SIMON, Stephen W. BURGESS, Walter A. SHAW
-
Publication number: 20120189602Abstract: The invention provides compositions and methods for treating pulmonary conditions and for reducing the negative effects of pulmonary inflammation. Such compositions and methods employ protease inhibitors and a lung surfactant mixture. The compositions and methods can also include lipase inhibitors (e.g. a phospholipase inhibitors) and anti-oxidants.Type: ApplicationFiled: January 4, 2011Publication date: July 26, 2012Inventor: Charles G. Cochrane
-
Patent number: 7863241Abstract: The invention provides compositions and methods for treating pulmonary conditions and for reducing the negative effects of pulmonary inflammation. Such compositions and methods employ protease inhibitors and a lung surfactant mixture. The compositions and methods can also include lipase inhibitors (e.g. a phospholipase inhibitors) and anti-oxidants.Type: GrantFiled: October 22, 2004Date of Patent: January 4, 2011Assignee: The Scripps Research InstituteInventor: Charles G. Cochrane
-
Patent number: 6613734Abstract: The present invention discloses useful surfactant molecules including polypeptides, proteins, and a variety of other organic molecules, as well as methods of making and using same. Surfactant compositions, including liposomal surfactant compositions, are also disclosed. In one preferred embodiment, a pulmonary surfactant composition comprises one or more pharmaceutically acceptable phospholipids admixed with a polypeptide comprising about 10 to 60 amino acid residues, wherein the polypeptide includes a sequence constituted by alternating groupings of charged amino acid residues and uncharged amino acid residues.Type: GrantFiled: June 7, 1995Date of Patent: September 2, 2003Assignee: The Scripps Research InstituteInventors: Charles G. Cochrane, Susan D. Revak
-
Publication number: 20030099696Abstract: The present invention discloses useful surfactant molecules including polypeptides, proteins, and a variety of other organic molecules, as well as methods of making and using same. Surfactant compositions, including liposomal surfactant compositions, are also disclosed. In one preferred embodiment, a pulmonary surfactant composition comprises one or more pharmaceutically acceptable phospholipids admixed with a polypeptide comprising about 10 to 60 amino acid residues, wherein the polypeptide includes a sequence constituted by alternating groupings of charged amino acid residues and uncharged amino acid residues.Type: ApplicationFiled: June 7, 1995Publication date: May 29, 2003Inventors: CHARLES G. COCHRANE, SUSAN D. REVAK
-
Patent number: 6013619Abstract: The present invention discloses useful surfactant molecules including polypeptides, proteins, and a variety of other organic molecules, as well as methods of making and using same. Surfactant compositions, including liposomal surfactant compositions, are also disclosed. Use of the surfactant molecules of the present invention in pulmonary lavage procedures for a variety of therapeutic applications is also disclosed, including the treatment of respiratory distress syndrome; the removal of inflammatory exudate from inflamed lung tissues; and the treament of meconium aspiration syndrome in infants.Type: GrantFiled: April 28, 1997Date of Patent: January 11, 2000Assignee: The Scripps Research InstituteInventors: Charles G. Cochrane, Susan D. Revak
-
Patent number: 5831032Abstract: Polypeptide analogs, antibodies, diagnostic and therapeutic compositions as well as methods for detecting the presence of IL-8 and preventing the inflammatory response in patients are described.Type: GrantFiled: May 6, 1996Date of Patent: November 3, 1998Assignee: The Scripps Research InstituteInventors: Ingrid U. Schraufstatter, Charles G. Cochrane
-
Patent number: 5789381Abstract: The present invention discloses useful peptides and synthetic pulmonary surfactants, as well as methods of making and using same. In one preferred embodiment, a synthetic pulmonary surfactant comprises one or more pharmaceutically acceptable phospholipids admixed with a polypeptide comprising at least 10 amino acid residues and no more than about 60 amino acid residues, said polypeptide including a sequence having alternating hydrophobic and hydrophilic amino acid residue regions. In other embodiments, a surfactant peptide has an amino acid residue sequence selected from the group consisting of KLLLLKLLLLKLLLLKLLLLK, KLLLLLLLLKLLLLLLLLKLL, and KKLLLLLLLKKLLLLLLLKKL.Type: GrantFiled: April 11, 1995Date of Patent: August 4, 1998Assignee: The Scripps Research InstituteInventors: Charles G. Cochrane, Susan D. Revak
-
Patent number: 5407914Abstract: The present invention discloses useful peptides and synthetic pulmonary surfactants, as well as methods of making and using same. In a preferred embodiment, a synthetic pulmonary surfactant comprises one or more pharmaceutically acceptable phospholipids admixed with a polypeptide comprising at least 10 amino acid residues and no more than about 60 amino acid residues, said polypeptide including a sequence having alternating hydrophobic and hydrophilic amino acid residue regions. In other embodiments, a surfactant peptide has an amino acid residue sequence selected from the group consisting of KLLLLKLLLLKLLLLKLLLLK, KLLLLLLLLKLLLLLLLLKLL, and KKLLLLLLLKKLLLLLLLKKL.Type: GrantFiled: May 12, 1993Date of Patent: April 18, 1995Assignee: The Scripps Research InstituteInventors: Charles G. Cochrane, Susan D. Revak
-
Patent number: 5260273Abstract: A synthetic pulmonary surfactant comprising a pharmaceutically acceptable phospholipid admixed with a polypeptide comprising at least 10 amino acid residues and no more than about 60 amino acid residues, said polypeptide including a sequence having alternating hydrophobic and hydrophilic amino acid residue regions represented by the formula (Z.sub.a U.sub.b).sub.c Z.sub.d, wherein:Z is a hydrophilic amino acid residue independently selected from the group consisting of R and K;U is a hydrophobic amino acid residue independently selected from the group consisting of V, I, L, C, Y and F;a has an average value of about 1 to about 5;b has an average value of about 3 to about 20;c is 1 to 10; andd is 1 to 3;said polypeptide, when admixed with a pharmaceutically acceptable phospholipid, forming a synthetic pulmonary surfactant having a surfactant activity greater than the surfactant activity of the phospholipid alone.Type: GrantFiled: June 14, 1991Date of Patent: November 9, 1993Assignee: The Scripps Research InstituteInventors: Charles G. Cochrane, Susan D. Revak
-
Patent number: 5164369Abstract: The present invention relates to a human SP18 monomer protein-related polypeptide useful in forming a synthetic pulmonary surfactant. The present invention also relates to a method of treating neonatal respiratory distress syndrome comprising adminstering a therapeutically effective amount of synthetic pulmonary of the present invention. Further contemplated by the present invention is a composition containing human SP18 monomer and human SP18 dimer but no other pulmonary surfactant proteins. A recombinant DNA molecule capable of expressing, without post-translational proteolytic processing, mature human SP18 monomer, and methods of using the recombinant DNA molecule are also contemplated.Type: GrantFiled: January 4, 1989Date of Patent: November 17, 1992Assignee: The Scripps Research InstituteInventors: Charles G. Cochrane, Susan D. Revak
-
Patent number: 4980279Abstract: A synthetic polypeptide is disclosed that substantially corresponds in sequence to a portion of the amino acid residue sequence of the 90 amino acid residue extra type III domain of human cellular fibronectin from about position 36 to about position 60 from the amino-terminus. The polypeptide contains about 10 to about 25 amino acid residues. Also disclosed are antibodies and methods of using both the polypeptide and antibodies.Type: GrantFiled: April 15, 1986Date of Patent: December 25, 1990Assignee: Scripps Clinic and Research FoundationInventors: John H. Peters, Mark H. Ginsberg, Charles G. Cochrane